Breaking News Instant updates and real-time market news.

2021-03-09 04:55:00 PRO Pros Holdings $44.52 / -1.945 (-4.19%) 04:55 03/09/21 03/09 04:55 03/09/21 04:55	Pros Holdings management to meet virtually with Needham Virtual Meeting to be held on March 9 hosted by Needham.	09 Mar
PRO Pros Holdings $44.52 / -1.945 (-4.19%) 12/17/20 Northland Pros Holdings price target raised to $61 from $56 at Northland 10/30/20 Fly Intel: Top five analyst downgrades 10/30/20 RBC Capital Pros Holdings downgraded to Sector Perform from Outperform at RBC Capital 10/30/20 KeyBanc Pros Holdings downgraded to Sector Weight from Overweight at KeyBanc

2021-03-09 04:55:00

PRO

Pros Holdings

$44.52 / -1.945 (-4.19%)

04:55

03/09/21

03/09

04:55

03/09/21

04:55

Pros Holdings management to meet virtually with Needham

Virtual Meeting to be held on March 9 hosted by Needham.

09
Mar

PRO Pros Holdings

$44.52 / -1.945 (-4.19%)

12/17/20 Northland: Pros Holdings price target raised to $61 from $56 at Northland

10/30/20: Fly Intel: Top five analyst downgrades

10/30/20 RBC Capital: Pros Holdings downgraded to Sector Perform from Outperform at RBC Capital

10/30/20 KeyBanc: Pros Holdings downgraded to Sector Weight from Overweight at KeyBanc

TODAY'S FREE FLY STORIES

Hot Stocks	Pfizer can deliver 10% more vaccine doses to U.S. by end of May, says CEO » 16:25 04/13/21 04/13 16:25 04/13/21 16:25 PFE Pfizer $37.15 / +0.17 (+0.46%) , BNTX BioNTech $129.64 / +8.13 (+6.69%) Pfizer (PFE) chairman and… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options PFE BNTX PFE Pfizer $37.15 / +0.17 (+0.46%) 09:47 Today White House says J&J pause will not significantly impact vaccination plan 07:53 Today Moderna up 7% to $149.10 after CDC, FDA recommend pause in J&J vaccine use 04/12/21 AgroFresh Solutions appoints Clinton Lewis Jr. as CEO 04/12/21 Myovant Sciences, Pfizer: First patient dosed in Phase 3 SERENE study BNTX BioNTech $129.64 / +8.13 (+6.69%) 04/09/21 Pfizer, BioNTech seek expansion of vaccine EUA to include 12-15 year olds 04/01/21 Pfizer, BioNTech: Vaccine more than 91% effective after 6 months in study 03/31/21 BioNTech, Pfizer: 'Positive' results of COVID-19 vaccine study in adolescents 03/30/21 BioNTech says evaluation of safety of third BNT162b2 dose initiated PFE BNTX PFE Pfizer $37.15 / +0.17 (+0.46%) 09:33 Today Morgan Stanley Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers 09:21 Today JPMorgan Vaccine pause 'incremental negative' for J&J, says JPMorgan 04/09/21 Pfizer to host conference call 04/06/21 RBC Capital Pfizer transferred with a Sector Perform at RBC Capital BNTX BioNTech $129.64 / +8.13 (+6.69%) 02/23/21 B. Riley Securities B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance 02/01/21 SVB Leerink Moderna price target raised to $80 from $69 at SVB Leerink 01/29/21 Piper Sandler Moderna, Pfizer keep Covid vaccine competitive advantage, says Piper Sandler 01/14/21 Morgan Stanley 80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley PFE PFE Pfizer $37.15 / +0.17 (+0.46%) 02/02/21 Pfizer raises FY21 adjusted EPS view to $3.10-$3.20, consensus $3.19 02/02/21 Pfizer raises FY21 adjusted EPS view to $3.10-$3.20, consensus $3.19 02/02/21 Pfizer reports Q4 adjusted EPS 42c, consensus 48c 02/01/21 Notable companies reporting before tomorrow's open 23 Jul PFE BNTX PFE Pfizer $37.15 / +0.17 (+0.46%) 09:48 Today NY replacing Tuesday's J&J vaccine appointments with Pfizer, Axios reports 04/12/21 Study shows Covid variant may evade protection from Pfizer vaccine, Reuters says 04/09/21 EU seeks contract for 1.8B COVID-19 doses with Pfizer, BioNTech, Reuters reports 04/06/21 Biden to say all U.S. adults should be vaccine-eligible by April 19, WSJ says BNTX BioNTech $129.64 / +8.13 (+6.69%) 04/12/21 Study shows Covid variant may evade protection from Pfizer vaccine, Reuters says 04/09/21 EU seeks contract for 1.8B COVID-19 doses with Pfizer, BioNTech, Reuters reports 04/06/21 Biden to say all U.S. adults should be vaccine-eligible by April 19, WSJ says 04/05/21 Pfizer working on new deal to supply COVID-19 vaccines to Israel, Reuters says PFE BNTX PFE Pfizer $37.15 / +0.17 (+0.46%) 11:12 Today Johnson & Johnson under pressure as FDA calls for pause on COVID vaccine 04/10/21 Opening Day: Phone maker UTime soars in public debut 04/09/21 Fly Intel: Wall Street's top stories for Friday 04/05/21 Fly Intel: Wall Street's top stories for Monday BNTX BioNTech $129.64 / +8.13 (+6.69%) 04/09/21 Fly Intel: Wall Street's top stories for Friday 04/05/21 Fly Intel: Wall Street's top stories for Monday 04/01/21 Fly Intel: Wall Street's top stories for Thursday 04/01/21 Fly Intel: Wall Street's top stories at midday 04/15/21 Horizons in Oncology Virtual Conference 05/24/21 Global Healthcare Virtual Conference 2021 05/04/21 Pfizer - PFE 05/10/21 BioNTech - BNTX 12/29/21 PDUFA Date for Lorbrena (Lorlatinib) April 2021 04/22/21 Pfizer Inc PFE BNTX PFE Pfizer $37.15 / +0.17 (+0.46%) 04/12/21 Unusually active option classes on open April 12th 04/09/21 Pfizer call volume above normal and directionally bullish 04/09/21 Early notable gainers among liquid option names on April 9th 03/15/21 Pfizer call volume above normal and directionally bullish BNTX BioNTech $129.64 / +8.13 (+6.69%) 02/17/21 Largest borrow rate increases among liquid names 01/26/21 BioNTech SE put volume heavy and directionally bearish 01/19/21 Largest borrow rate increases among liquid names 11/23/20 Largest borrow rate increases among liquid names
Initiation	MAG Silver initiated with a Neutral at CIBC » 16:25 04/13/21 04/13 16:25 04/13/21 16:25 MAG MAG Silver $17.05 / +0.27 (+1.61%) CIBC initiated coverage… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Options MAG MAG Silver $17.05 / +0.27 (+1.61%) 10/21/20 MAG Silver announces first production from Juanicipio MAG MAG Silver $17.05 / +0.27 (+1.61%) 02/08/21 Stifel MAG Silver price target raised to C$29 from C$27.75 at Stifel 01/28/21 BMO Capital MAG Silver price target lowered to C$22.50 from C$23.50 at BMO Capital 01/15/21 Raymond James MAG Silver price target raised to C$29 from C$26 at Raymond James 01/11/21 National Bank MAG Silver price target raised to C$35 from C$29.50 at National Bank MAG MAG Silver $17.05 / +0.27 (+1.61%) 03/17/21 Largest borrow rate increases among liquid names 11/13/20 MAG Silver options imply 5.4% move in share price post-earnings 10/14/20 Largest borrow rate increases among liquid names
Initiation	Gatos Silver initiated with an Outperformer at CIBC » 16:23 04/13/21 04/13 16:23 04/13/21 16:23 GATO Gatos Silver $10.19 / +0.49 (+5.05%) CIBC initiated coverage… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Syndicate On The Fly Events Options GATO Gatos Silver $10.19 / +0.49 (+5.05%) 03/11/21 Gatos Silver commences drilling at Santa Valeria project in Mexico 03/09/21 Gatos Silver increases ownership in LGJV to 70% from 51.5%, extinguishes WCF 02/19/21 Gatos Silver provides update on temporary power restriction at Cerro Los Gatos 02/01/21 Gatos Silver rises 23.9% GATO Gatos Silver $10.19 / +0.49 (+5.05%) 01/29/21 BMO Capital Gatos Silver downgraded to Market Perform from Outperform at BMO Capital 11/24/20 BMO Capital Gatos Silver initiated with an Outperform at BMO Capital 11/23/20 RBC Capital Gatos Silver initiated with an Outperform at RBC Capital 28 Oct GATO Gatos Silver $10.19 / +0.49 (+5.05%) 11/01/20 Opening Day: MediaAlpha jumps 64%, Root falls flat in debut 05/26/21 Gatos Silver Inc GATO Gatos Silver $10.19 / +0.49 (+5.05%) 04/07/21 new option listings and two option delistings on April 7th
Upgrade	Snap upgraded to Outperform upon assumption at Wedbush » 16:21 04/13/21 04/13 16:21 04/13/21 16:21 SNAP Snap $62.44 / + (+0.00%) As previously reported,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options SNAP Snap $62.44 / + (+0.00%) 03/17/21 Snap acquires Fit Analytics, terms not disclosed 03/03/21 Snap CEO sells 1.54M shares of common stock 02/23/21 Snap sees gross margins continuing to expand in 2021 02/23/21 Snap says Map feature reaches over 250M monthly active users SNAP Snap $62.44 / + (+0.00%) 16:12 Today Wedbush Snap assumed at Outperform from Neutral at Wedbush 04/06/21 Atlantic Equities Snap upgraded to Overweight from Neutral at Atlantic Equities 04/05/21 Evercore ISI Snap assumed with an Outperform at Evercore ISI 03/31/21 Wolfe Research Snap initiated with an Outperform at Wolfe Research SNAP Snap $62.44 / + (+0.00%) 02/04/21 Snap sees Q1 revenue $720M-$740M, consensus $704.57M 02/04/21 Snap reports Q4 adjusted EPS 9c, consensus 7c 02/04/21 Notable companies reporting after market close 10/20/20 Snap says 47%-50% year-over-year revenue growth in Q4 'attainable' SNAP Snap $62.44 / + (+0.00%) 04/06/21 Facebook, Apple and Niantic see a future in augmented -reality glasses, WSJ says 03/30/21 Snap developing new Spectacles with augmented reality, Information reports 03/05/21 Reddit hires Drew Vollero as CFO ahead of eventual IPO, NY Times reports 02/16/21 ByteDance looks to list Douyin in NY as Biden sets new mood, SCMP reports SNAP Snap $62.44 / + (+0.00%) 04/07/21 #SocialStocks: AR glasses seen as future of tech 04/06/21 Roku, Starbucks initiations among today's top calls on Wall Street 04/06/21 Fly Intel: Pre-market Movers 04/05/21 Roblox jumps as several Wall Street analysts initiate coverage with a Buy 04/22/21 Snap - SNAP SNAP Snap $62.44 / + (+0.00%) 04/12/21 Notable open interest changes for April 12th 04/08/21 Snap Inc. call buyer realizes 13% same-day gains 04/06/21 Unusually active option classes on open April 6th 03/26/21 Notable open interest changes for March 26th
Earnings	Nurix Therapeutics reports Q1 EPS (63c), consensus (46c) » 16:21 04/13/21 04/13 16:21 04/13/21 16:21 NRIX Nurix Therapeutics $26.44 / -0.065 (-0.25%) Reports Q1 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events Options NRIX Nurix Therapeutics $26.44 / -0.065 (-0.25%) 03/16/21 Nurix Therapeutics announces collaboration for drugs to treat pediatric cancers 01/07/21 Nurix Therapeutics expands strategic collaboration with Sanofi 10/26/20 Nurix appoints Robert Tjian as chairman of Scientific Advisory Board NRIX Nurix Therapeutics $26.44 / -0.065 (-0.25%) 02/17/21 Piper Sandler Nurix Therapeutics price target raised to $60 from $40 at Piper Sandler 02/16/21 Piper Sandler Nurix Therapeutics price target raised to $60 from $40 at Piper Sandler 01/29/21 JPMorgan Nurix Therapeutics price target raised to $56 from $34 at JPMorgan 11/24/20 Morgan Stanley Kymera Therapeutics price target raised to $45 from $27 at Morgan Stanley NRIX Nurix Therapeutics $26.44 / -0.065 (-0.25%) 02/16/21 Nurix Therapeutics reports Q4 EPS (51c), consensus (54c) 10/14/20 Nurix Therapeutics reports Q3 EPS (59c), consensus (41c) 05 Mar 24 Jul 05/24/21 Global Healthcare Virtual Conference 2021 05/06/21 Nurix Therapeutics, Inc. NRIX Nurix Therapeutics $26.44 / -0.065 (-0.25%) 03/17/21 new option listings on March 17th

Hot Stocks	Procter & Gamble raises quarterly dividend 10% to 86.98c per share » 16:21 04/13/21 04/13 16:21 04/13/21 16:21 PG Procter & Gamble $135.12 / -1.78 (-1.30%) The Board of Directors of… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options PG Procter & Gamble $135.12 / -1.78 (-1.30%) 15:47 Today Procter & Gamble announces multi-year partnership with Major League Soccer 03/28/21 Fly Intel: Top five weekend stock stories 02/12/21 Trian Fund exits nVent, increases stake in GE 01/22/21 Procter & Gamble licenses nasal swab to Rhinostics for Covid test PG Procter & Gamble $135.12 / -1.78 (-1.30%) 03/02/21 BofA Procter & Gamble removed from the US 1 List at BofA 01/28/21 Stifel Stifel downgrades Procter & Gamble to Hold on emerging headwinds 01/28/21 Stifel Procter & Gamble downgraded to Hold from Buy at Stifel 01/19/21 Bernstein Procter & Gamble initiated with a Market Perform at Bernstein PG Procter & Gamble $135.12 / -1.78 (-1.30%) 01/20/21 Procter & Gamble raises FY21 core EPS view to up 8%-10% from up 5%-8% 01/20/21 Procter & Gamble reports Q2 core EPS $1.64, consensus $1.51 01/19/21 Notable companies reporting before tomorrow's open 01/19/21 Notable companies reporting before tomorrow's open PG Procter & Gamble $135.12 / -1.78 (-1.30%) 04/09/21 P&G, China trade groups work to avoid Apple's new privacy rules, WSJ reports 03/27/21 Verizon, IBM among stocks to build income stream for long haul, Barron's says 11/13/20 Procter & Gamble new disinfectant on pace for $200M in sales, WSJ reports PG Procter & Gamble $135.12 / -1.78 (-1.30%) 01/20/21 Fly Intel: Wall Street's top stories for Wednesday 01/20/21 Fly Intel: Wall Street's top stories at midday 01/20/21 Fly Intel: Pre-market Movers 01/06/21 Coca-Cola, PepsiCo downgrades among today's top calls on Wall Street 04/20/21 Procter & Gamble - PG PG Procter & Gamble $135.12 / -1.78 (-1.30%) 02/26/21 Unusually active option classes on open February 26th 12/09/20 Notable open interest changes for December 9th 10/20/20 Unusually active option classes on open October 20th
Hot Stocks	ProQR Therapeutics announces journal publication on sepofarsen trial » 16:20 04/13/21 04/13 16:20 04/13/21 16:20 PRQR ProQR Therapeutics $6.01 / +0.05 (+0.84%) ProQR Therapeutics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly PRQR ProQR Therapeutics $6.01 / +0.05 (+0.84%) 03/25/21 ProQR Therapeutics trading resumes 03/25/21 ProQR Therapeutics trading halted, volatility trading pause 03/24/21 ProQR Therapeutics releases results from clinical trial of QR-421a 01/07/21 ProQR Therapeutics completes enrollment in trial of sepofarsen PRQR ProQR Therapeutics $6.01 / +0.05 (+0.84%) 03/25/21 Citi ProQR Therapeutics price target raised to $44 from $33 at Citi 03/24/21 Cantor Fitzgerald ProQR Therapeutics price target raised to $33 from $22 at Cantor Fitzgerald 03/24/21 JMP Securities ProQR Therapeutics price target raised to $35 from $19 at JMP Securities 11/02/20 Cantor Fitzgerald ProQR Therapeutics assumed with an Overweight at Cantor Fitzgerald PRQR ProQR Therapeutics $6.01 / +0.05 (+0.84%) 11/16/20 ProQR Therapeutics reports Q3 EPS (EUR0.26) vs. (EUR0.31) last year 31 Mar PRQR ProQR Therapeutics $6.01 / +0.05 (+0.84%) 03/31/21 Fly Intel: Pre-market Movers
Options	Closing CBOE SPX and VIX Index summary for April 13th » 16:20 04/13/21 04/13 16:20 04/13/21 16:20 VIX Volatility Index S&P 500 Options / + The CBOE Volatility Index… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Options VIX Volatility Index S&P 500 Options / + 09:18 Today Overnight activity included 960 trades in SPX and 47 trades in VIX 04/12/21 Closing CBOE SPX and VIX Index summary for April 12th 04/12/21 Overnight activity included 1154 trades in SPX and 64 trades in VIX 04/09/21 Closing CBOE SPX and VIX Index summary for April 9th
Upgrade	Nihon Kohden upgraded to Overweight from Equal Weight at Morgan Stanley » 16:19 04/13/21 04/13 16:19 04/13/21 16:19 NHNKY Nihon Kohden $14.29 / -0.26 (-1.79%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research NHNKY Nihon Kohden $14.29 / -0.26 (-1.79%) 02/10/21 Daiwa Nihon Kohden downgraded to Neutral from Outperform at Daiwa 01/07/21 Mizuho Nihon Kohden downgraded to Neutral from Buy at Mizuho
Hot Stocks	Shore Bancshares announces new branch in South Ocean City, Maryland » 16:19 04/13/21 04/13 16:19 04/13/21 16:19 SHBI Shore Bancshares $17.00 / -0.04 (-0.23%) Shore Bancshares… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events SHBI Shore Bancshares $17.00 / -0.04 (-0.23%) 03/03/21 Shore Bancshares, Severn to merge in roughly $146M deal 11/24/20 Shore Bancshares to repurchase up to $5M of its common stock SHBI Shore Bancshares $17.00 / -0.04 (-0.23%) 03/08/21 Keefe Bruyette Shore Bancshares upgraded to Outperform from Market Perform at Keefe Bruyette SHBI Shore Bancshares $17.00 / -0.04 (-0.23%) 01/28/21 Shore Bancshares reports Q4 cont-op EPS 32c, consensus 23c 10/22/20 Shore Bancshares reports Q3 EPS 27c, consensus 18c 05/12/21 Shore Bancshares, Inc.

Hot Stocks	Results in Endo's phase 3 study show meaningful improvement in severe cellulite » 16:19 04/13/21 04/13 16:19 04/13/21 16:19 ENDP Endo $6.11 / -0.07 (-1.13%) The company states:… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options ENDP Endo $6.11 / -0.07 (-1.13%) 04/07/21 Endo comments on default liability judgment in Tennessee State court case 02/16/21 Paulson & Co. buys Exxon, exits Qiagen in Q4 01/05/21 Endo subsidiary enters into agreement with Radius Health for abaloparatide 01/05/21 Radius Health enters commercial agreement with Paladin Labs for abaloparatide ENDP Endo $6.11 / -0.07 (-1.13%) 04/06/21 RBC Capital Endo transferred with a Sector Perform at RBC Capital 03/08/21 Barclays Endo price target raised to $7 from $6 at Barclays 03/04/21 Citi Endo price target lowered to $10 from $11 at Citi 01/19/21 Citi Endo price target raised to $9 from $7 at Citi ENDP Endo $6.11 / -0.07 (-1.13%) 02/25/21 Endo sees Q1 adjusted EPS 40c-50c, consensus 53c 02/25/21 Endo sees Q1 adjusted EPS 40c-50c, consensus 53c 02/25/21 Endo sees FY21 adjusted EPS $1.80-$2.30, consensus $2.32 02/25/21 Endo reports Q4 adjusted EPS 75c, consensus 48c ENDP Endo $6.11 / -0.07 (-1.13%) 10/21/20 Purdue Pharma to plead guilty in $8B-plus deal, AP reports ENDP Endo $6.11 / -0.07 (-1.13%) 02/25/21 Fly Intel: After-Hours Movers 10/19/20 Fly Intel: Wall Street's top stories for Monday 10/19/20 Fly Intel: Wall Street's top stories at midday ENDP Endo $6.11 / -0.07 (-1.13%) 12/18/20 Opening seller repeats Endo straddle sale 11/05/20 Endo options imply 66.9% move in share price post-earnings
Hot Stocks	Stitch Fix CEO Lake to transition to executive chairperson role » 16:18 04/13/21 04/13 16:18 04/13/21 16:18 SFIX Stitch Fix $49.46 / -1.3 (-2.56%) Stitch Fix, Inc.… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options SFIX Stitch Fix $49.46 / -1.3 (-2.56%) 03/23/21 Stitch Fix appoints Sharon Chiarella as Chief Product Officer 03/08/21 Stitch Fix says excited about direct buy active client demand 03/08/21 Stitch Fix drops 23% to $52.30 after reporting mixed Q2 results 12/10/20 Stitch Fix CEO: Our success rate was the highest ever during Q1 SFIX Stitch Fix $49.46 / -1.3 (-2.56%) 04/05/21 Evercore ISI Stitch Fix initiated with an Outperform at Evercore ISI 03/09/21 Fly Intel: Top five analyst downgrades 03/09/21 Canaccord Stitch Fix price target lowered to $68 from $72 at Canaccord 03/09/21 KeyBanc Stitch Fix price target lowered to $75 from $95 at KeyBanc SFIX Stitch Fix $49.46 / -1.3 (-2.56%) 03/08/21 Stitch Fix cuts FY21 revenue view to $2.02B-$2.05B from $2.05B-$2.14B 03/08/21 Stitch Fix sees Q3 revenue $505M-$515M, consensus $522.97M 03/08/21 Stitch Fix reports Q2 EPS (20c), consensus (22c) 03/08/21 Notable companies reporting after market close SFIX Stitch Fix $49.46 / -1.3 (-2.56%) 03/09/21 Fly Intel: Wall Street's top stories for Tuesday 03/09/21 Fly Intel: Wall Street's top stories at midday 03/09/21 Tesla upgrade, Best Buy initiation among today's top calls on Wall Street 03/09/21 Fly Intel: Pre-market Movers SFIX Stitch Fix $49.46 / -1.3 (-2.56%) 03/08/21 Stitch Fix options imply 27.9% move in share price post-earnings 01/05/21 Stitch Fix put volume heavy and directionally bearish 12/28/20 Stitch Fix put volume heavy and directionally bearish 12/07/20 Stitch Fix options imply 21.3% move in share price post-earnings
Earnings	Flexion sees FY21 revenue $120M-$130M, consensus $137.42M » 16:18 04/13/21 04/13 16:18 04/13/21 16:18 FLXN Flexion $9.37 / +1.05 (+12.62%) FY21 total operating… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate FLXN Flexion $9.37 / +1.05 (+12.62%) 03/31/21 Flexion announces first patient treated in FX201 Phase 1b trial 03/01/21 Flexion announces FDA clearance for FX301 IND application 02/18/21 Flexion to advance FX201 into high dose cohort of Phase 1 trial 02/01/21 NBRPA, Sheryl Swoopes, Flexion partner to raise ZILRETTA awarness FLXN Flexion $9.37 / +1.05 (+12.62%) 04/06/21 RBC Capital Flexion transferred with an Outperform at RBC Capital 08/20/20 Goldman Sachs Flexion initiated with a Neutral at Goldman Sachs 07/30/20 Oppenheimer Flexion initiated with an Outperform at Oppenheimer 07/29/20 Fly Intel: Top five analyst initiations FLXN Flexion $9.37 / +1.05 (+12.62%) 16:17 Today Flexion reports preliminary Q1 revenue $24.6M, consensus $25.23M 01/13/21 Flexion sees 2020 revenue $85.5M, consensus $84.88M 01/13/21 Flexion sees Q4 revenue $26.3M, consensus $25.66M 11/04/20 Flexion reports Q3 EPS (50c), consensus (51c) 21 May
Downgrade	Facebook assumed with Neutral at Wedbush, cites privacy risk » 16:17 04/13/21 04/13 16:17 04/13/21 16:17 FB Facebook $309.74 / -1.96 (-0.63%) , AAPL Apple $134.41 / +3.14 (+2.39%) Wedbush analyst Ygal… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options FB AAPL FB Facebook $309.74 / -1.96 (-0.63%) 04/09/21 Facebook removes 16,000 groups trading fake reviews, says U.K.'s CMA 04/09/21 Facebook to convert part of Menlo Park HQ into vaccination site 04/08/21 Facebook tweets today's technical glitch was 'quickly resolved' 04/05/21 Facebook announces new ad solution, Dynamic Ads for Streaming AAPL Apple $134.41 / +3.14 (+2.39%) 12:10 Today Apple confirms plans for 'Spring Loaded' event on April 20 06:33 Today Eli Lilly announces Diogo Rau as chief information, digital officer 04/12/21 Apple Mac sales implied up 65% vs. 22% consensus, Gene Munster says 04/02/21 Apple adds over 30 titles to Arcade, bringing total to over 180 games FB AAPL FB Facebook $309.74 / -1.96 (-0.63%) 16:09 Today Wedbush Facebook assumed at Neutral from Outperform at Wedbush 04/05/21 Evercore ISI Facebook assumed with an Outperform at Evercore ISI 03/31/21 Wolfe Research Facebook initiated with an Outperform at Wolfe Research 03/29/21 Deutsche Bank Facebook price target raised to $385 from $355 at Deutsche Bank AAPL Apple $134.41 / +3.14 (+2.39%) 04/12/21 Canaccord Canaccord upgrades Tesla with over $1,000 target on 'Apple-esque' ecosystem 04/09/21 Citi Citi tells investors to focus on Apple's capital deployment, iPhone gains 04/08/21 Piper Sandler Teen iPhone ownership continues to increase, says Piper Sandler 04/06/21 Cowen Apple's News product a key growth pillar, says Cowen FB AAPL FB Facebook $309.74 / -1.96 (-0.63%) 02/16/21 Tiger Global bought DoorDash and 1Life during Q4, sold out of Alphabet 01/27/21 Facebook reports Q4 EPS $3.88, consensus $3.22 01/27/21 Notable companies reporting after market close 10/29/20 Facebook sees Q4 ad revenue growth rate higher than Q3 AAPL Apple $134.41 / +3.14 (+2.39%) 01/27/21 Apple reports Q1 EPS $1.70, consensus $1.41 01/27/21 Notable companies reporting after market close 10/29/20 Apple says Q4 results were ahead of expectations 10/29/20 Apple reports Q4 Services revenue $14.55B vs. $12.51B last year FB AAPL FB Facebook $309.74 / -1.96 (-0.63%) 04/08/21 Facebook experiencing technical problems, Bloomberg reports 04/08/21 Facebook not planning to notify users impacted by data leak, Reuters reports 04/07/21 Facebook didn't hire Black employees because of 'culture fit,' BI reports 04/07/21 Facebook, Google donated to GOP group that pushes voter supression laws, BI says AAPL Apple $134.41 / +3.14 (+2.39%) 05:57 Today Apple's April 20 event prematurely revelead by Siri, MacRumors reports 04/12/21 Apple faces supply constraints with iPad Pros, Bloomberg reports 04/11/21 Apple agrees to testify before Senate on app store concerns, Reuters reports 04/09/21 Apple hires former WarnerMedia executive Jesse Henderson, Information says FB AAPL FB Facebook $309.74 / -1.96 (-0.63%) 04/07/21 #SocialStocks: AR glasses seen as future of tech 04/06/21 Roku, Starbucks initiations among today's top calls on Wall Street 04/01/21 Alphabet, Facebook initiations among today's top calls on Wall Street 03/31/21 #SocialStocks: Social media CEOs give congressional testimony yet again AAPL Apple $134.41 / +3.14 (+2.39%) 12:34 Today Game On: GameStop may be looking for new CEO 04/12/21 Tesla, Chipotle upgrades among today's top calls on Wall Street 04/11/21 On the Fly: The Week in SPAC News 04/08/21 Fly Intel: Wall Street's top stories for Thursday 04/22/21 Digital Media 04/28/21 Apple - AAPL 04/28/21 Facebook - FB 05/26/21 Facebook Inc. FB AAPL FB Facebook $309.74 / -1.96 (-0.63%) 03/18/21 Facebook call volume above normal and directionally bullish 02/16/21 Facebook call volume above normal and directionally bullish 01/27/21 Facebook options imply 11.6% move in share price post-earnings 01/15/21 Facebook call volume above normal and directionally bullish AAPL Apple $134.41 / +3.14 (+2.39%) 08:55 Today Notable open interest changes for April 13th 04/12/21 Notable open interest changes for April 12th 04/09/21 Notable open interest changes for April 9th 04/09/21 Unusual call flow in option market yesterday
Earnings	Flexion reports preliminary Q1 revenue $24.6M, consensus $25.23M » 16:17 04/13/21 04/13 16:17 04/13/21 16:17 FLXN Flexion $9.37 / +1.05 (+12.62%) As of March 31, the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate FLXN Flexion $9.37 / +1.05 (+12.62%) 03/31/21 Flexion announces first patient treated in FX201 Phase 1b trial 03/01/21 Flexion announces FDA clearance for FX301 IND application 02/18/21 Flexion to advance FX201 into high dose cohort of Phase 1 trial 02/01/21 NBRPA, Sheryl Swoopes, Flexion partner to raise ZILRETTA awarness FLXN Flexion $9.37 / +1.05 (+12.62%) 04/06/21 RBC Capital Flexion transferred with an Outperform at RBC Capital 08/20/20 Goldman Sachs Flexion initiated with a Neutral at Goldman Sachs 07/30/20 Oppenheimer Flexion initiated with an Outperform at Oppenheimer 07/29/20 Fly Intel: Top five analyst initiations FLXN Flexion $9.37 / +1.05 (+12.62%) 01/13/21 Flexion sees 2020 revenue $85.5M, consensus $84.88M 01/13/21 Flexion sees Q4 revenue $26.3M, consensus $25.66M 11/04/20 Flexion reports Q3 EPS (50c), consensus (51c) 21 May

Recommendations	Organigram price target lowered to C$3.75 from C$4 at Alliance Global Partners » 16:17 04/13/21 04/13 16:17 04/13/21 16:17 OGI Organigram $2.92 / +0.145 (+5.23%) Alliance Global Partners… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options OGI Organigram $2.92 / +0.145 (+5.23%) 04/06/21 Organigram acquires The Edibles & Infusions Corporation for C$22M 03/15/21 Organigram CEO looking forward to bring products to U.S. market when time comes 03/11/21 Organigram jumps 36% to $3.95 after investment from British American Tobacco 03/11/21 Organigram, British American Tobacco enter product development collaboration OGI Organigram $2.92 / +0.145 (+5.23%) 04/07/21 BMO Capital Organigram upgraded to Market Perform from Underperform at BMO Capital 03/16/21 Stifel Organigram price target raised to C$6 from C$1.90 at Stifel 03/15/21 BMO Capital Organigram price target raised to C$4 from C$2 at BMO Capital 03/12/21 CIBC Organigram price target raised to C$5 from C$4.25 at CIBC OGI Organigram $2.92 / +0.145 (+5.23%) 11/30/20 Organigram reports Q4 EPS (19.9c) va. (14.4c) last year OGI Organigram $2.92 / +0.145 (+5.23%) 02/10/21 Tilray jumps as Reddit crowd turns attention to pot, Bloomberg says OGI Organigram $2.92 / +0.145 (+5.23%) 04/08/21 Rising High: Canopy Growth to acquire The Supreme Cannabis Company in $435M deal 03/11/21 Fly Intel: Wall Street's top stories for Thursday 03/11/21 Fly Intel: Wall Street's top stories at midday 02/11/21 Tilray, other pot stocks slide as Reddit trade loses momentum 08:00 Today Organigram - OGI OGI Organigram $2.92 / +0.145 (+5.23%) 03/11/21 Unusually active option classes on open March 11th 02/22/21 Unusually active option classes on open February 22nd 02/04/21 Unusually active option classes on open February 4th 12/03/20 Largest borrow rate increases among liquid names
Technical Analysis	NASDAQ market internals summary » 16:17 04/13/21 04/13 16:17 04/13/21 16:17 $NSD NASDAQ Market Internals / + Volume was above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Technical Analysis $NSD NASDAQ Market Internals / + 15:17 Today NASDAQ market internals summary 14:17 Today NASDAQ market internals summary 13:17 Today NASDAQ market internals summary 12:17 Today NASDAQ market internals summary
Earnings	PerkinElmer sees Q1 reported revenue growth 98%, consensus $1.19B » 16:16 04/13/21 04/13 16:16 04/13/21 16:16 PKI PerkinElmer $135.39 / +2.695 (+2.03%) PerkinElmer announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events PKI PerkinElmer $135.39 / +2.695 (+2.03%) 03/29/21 PerkinElmer's Horizon Discovery announces extention of gene modulation portfolio 03/10/21 Quidel slips, drags on peers as demand for testing 'softens significantly' 03/09/21 PerkinElmer launches comprehensive solutions for detecting SARS-CoV-2 mutations 02/23/21 PerkinElmer launches point of care Covid-19 antigen test for mass screening PKI PerkinElmer $135.39 / +2.695 (+2.03%) 02/03/21 Citi PerkinElmer price target raised to $155 from $150 at Citi 01/07/21 Piper Sandler Oxford Immunotec downgraded to Neutral from Overweight at Piper Sandler 01/07/21 Wells Fargo PerkinElmer upgraded to Overweight from Equal Weight at Wells Fargo 01/07/21 Wells Fargo PerkinElmer upgraded to Overweight from Equal Weight at Wells Fargo PKI PerkinElmer $135.39 / +2.695 (+2.03%) 02/02/21 PerkinElmer sees Q1 adjusted EPS of at least $3.00, consensus $2.40 02/02/21 PerkinElmer sees FY21 adjusted EPS at least $8.50, consensus $8.88 02/02/21 PerkinElmer reports Q4 adjusted EPS $3.96, consensus $3.00 01/11/21 PerkinElmer sees Q4 adjusted EPS 'at least' $3.60, consensus $2.79 PKI PerkinElmer $135.39 / +2.695 (+2.03%) 01/07/21 Fly Intel: Pre-market Movers 04/27/21 PerkinElmer, Inc.
Technical Analysis	NYSE market internals summary » 16:16 04/13/21 04/13 16:16 04/13/21 16:16 $NYE NYSE Market Internals / + Volume was average for… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Technical Analysis $NYE NYSE Market Internals / + 15:16 Today NYSE market internals summary 14:16 Today NYSE market internals summary 13:16 Today NYSE market internals summary 12:16 Today NYSE market internals summary
Initiation	Twitter assumed with a Neutral at Wedbush » 16:14 04/13/21 04/13 16:14 04/13/21 16:14 TWTR Twitter $72.42 / +1.55 (+2.19%) Wedbush analyst Ygal… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options TWTR Twitter $72.42 / +1.55 (+2.19%) 04/12/21 Twitter building team in Ghana to establish Africa presence 04/08/21 Twitter integrates Nielsen's cross-media solutions into video ad platform 03/23/21 Twitter welcomes Reshuffle team amid API improvements 03/11/21 Super League Gaming to acquire Mobcrush, terms not disclosed TWTR Twitter $72.42 / +1.55 (+2.19%) 04/05/21 Evercore ISI Twitter assumed with an In Line at Evercore ISI 03/31/21 Wolfe Research Twitter initiated with a Peer Perform at Wolfe Research 03/30/21 Morgan Stanley Twitter price target lowered to $68 from $75 at Morgan Stanley 03/29/21 Fly Intel: Top five analyst upgrades TWTR Twitter $72.42 / +1.55 (+2.19%) 02/25/21 Twitter announces three long-term goals, aims to double sales in 2023 02/09/21 Twitter sees Q1 revenue $940M-$1.04B, consensus $965.14M 02/09/21 Twitter reports Q4 adjusted EPS 38c, consensus 31c 02/09/21 Notable companies reporting after market close TWTR Twitter $72.42 / +1.55 (+2.19%) 04/07/21 Twitter has previously discussed $4B acquisition of Clubhouse, Bloomberg reports 04/07/21 Twitter discussed $4B takeover deal for Clubhouse, Bloomberg says 04/07/21 Twitter says eventually users may complete shopping on service, Reuters reports 04/05/21 Justice Thomas suggests utility-like regulation for some tech, CNBC says TWTR Twitter $72.42 / +1.55 (+2.19%) 04/08/21 Fly Intel: Wall Street's top stories for Thursday 04/08/21 Fly Intel: Wall Street's top stories at midday 04/07/21 #SocialStocks: AR glasses seen as future of tech 04/06/21 Roku, Starbucks initiations among today's top calls on Wall Street 05/24/21 Global Technology, Media & Communications Virtual Conference 04/29/21 Twitter - TWTR TWTR Twitter $72.42 / +1.55 (+2.19%) 04/08/21 Twitter call volume above normal and directionally bullish 04/07/21 Unusual call flow in option market yesterday 04/06/21 Twitter call volume above normal and directionally bullish 04/06/21 Early notable gainers among liquid option names on April 6th

Hot Stocks	Kura Sushi reports Q2 comparable restaurant sales down 60% » 16:13 04/13/21 04/13 16:13 04/13/21 16:13 KRUS Kura Sushi $31.34 / +0.27 (+0.87%) Adjusted EBITDA was… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Earnings Events KRUS Kura Sushi $31.34 / +0.27 (+0.87%) 04/06/21 Craig-Hallum Kura Sushi price target raised to $40 from $25 at Craig-Hallum 03/04/21 Stephens Kura Sushi price target raised to $42 from $28 at Stephens 03/03/21 BTIG Kura Sushi price target raised to $40 from $22 at BTIG 01/12/21 Craig-Hallum Kura Sushi upgraded to Buy from Hold at Craig-Hallum KRUS Kura Sushi $31.34 / +0.27 (+0.87%) 16:12 Today Kura Sushi reports Q2 adjusted EPS (78c), consensus (78c) 01/11/21 Kura Sushi reports Q1 adjusted EPS (71c), consensus (65c) 11/16/20 Kura Sushi reports Q4 EPS (82c), consensus (58c) 17:00 Today Kura Sushi - KRUS
Initiation	Overstock.com assumed with an Outperform at Wedbush » 16:13 04/13/21 04/13 16:13 04/13/21 16:13 OSTK Overstock.com $77.77 / +5.47 (+7.57%) Wedbush analyst Ygal… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options OSTK Overstock.com $77.77 / +5.47 (+7.57%) 03/30/21 Overstock.com welcomes Elizabeth Solomon as chief marketing officer 02/26/21 SEC subpoenas Overstock over guidance, management communications 02/03/21 Overstock.com CEO says government contract 'going slow' 01/26/21 Overstock.com converting Medici Ventures to limited partnership OSTK Overstock.com $77.77 / +5.47 (+7.57%) 04/09/21 Piper Sandler Piper calls Overstock 'most mispriced stock' with 'tremendous risk/reward' 02/25/21 DA Davidson Overstock.com price target raised to $121 from $103 at DA Davidson 02/25/21 Wedbush Overstock.com price target lowered to $100 from $126 at Wedbush 02/25/21 BofA Overstock.com upgraded to Buy from Neutral at BofA OSTK Overstock.com $77.77 / +5.47 (+7.57%) 02/24/21 Overstock.com reports Q4 EPS 26c, consensus 4c 10/29/20 Overstock.com reports Q3 EPS 50c, two est. (23c) 12 Aug OSTK Overstock.com $77.77 / +5.47 (+7.57%) 12/22/20 Overstock eyes potential brick-and-mortar partnerships, AdWeek says OSTK Overstock.com $77.77 / +5.47 (+7.57%) 04/09/21 The Intersection: Crypto and Wall Street This Week 04/09/21 Honeywell, Carnival upgrades among today's top calls on Wall Street 03/26/21 The Intersection: Crypto and Wall Street This Week 03/19/21 The Intersection: Crypto and Wall Street This Week 05/13/21 Overstock.com, Inc. OSTK Overstock.com $77.77 / +5.47 (+7.57%) 03/19/21 Overstock com call volume above normal and directionally bullish 03/18/21 Overstock com call volume above normal and directionally bullish 02/18/21 Overstock com put volume heavy and directionally bearish 01/22/21 Overstock com call volume above normal and directionally bullish
Initiation	Alphabet assumed with Outperform, added to 'Best Ideas' at Wedbush » 16:12 04/13/21 04/13 16:12 04/13/21 16:12 GOOG Alphabet $2,270.15 / +14.75 (+0.65%) , GOOGL Alphabet Class A $2,257.06 / +12.325 (+0.55%) Wedbush analyst Ygal… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options GOOG GOOGL GOOG Alphabet $2,270.15 / +14.75 (+0.65%) 09:02 Today Broadcom, Google Cloud to accelerate digital transformation in enterprise 04/12/21 Nvidia announces partnerships for AI-on-5G platform 04/07/21 LiveRamp Google in pact to enable identity in the Cloud 04/05/21 Oracle says 'Google platform just got bigger' after Supreme Court ruling GOOGL Alphabet Class A $2,257.06 / +12.325 (+0.55%) 09:02 Today Broadcom, Google Cloud to accelerate digital transformation in enterprise 04/12/21 Nvidia announces partnerships for AI-on-5G platform 04/05/21 Oracle says 'Google platform just got bigger' after Supreme Court ruling 04/05/21 Supreme Court overturns Oracle's copyright win over Google GOOG GOOGL GOOG Alphabet $2,270.15 / +14.75 (+0.65%) 04/05/21 Evercore ISI Alphabet assumed with an Outperform at Evercore ISI 04/01/21 Morgan Stanley Microsoft making progress toward being 'Netflix of Gaming,' says Morgan Stanley 03/31/21 Wolfe Research Alphabet initiated with an Outperform at Wolfe Research 03/30/21 Fly Intel: Top five analyst upgrades GOOGL Alphabet Class A $2,257.06 / +12.325 (+0.55%) 04/12/21 BMO Capital Microsoft price target raised to $280 from $270 at BMO Capital 04/09/21 Argus Alphabet price target raised to $2,500 from $2,400 at Argus 04/05/21 Evercore ISI Alphabet assumed with an Outperform at Evercore ISI 04/01/21 Morgan Stanley Microsoft making progress toward being 'Netflix of Gaming,' says Morgan Stanley GOOG GOOGL GOOG Alphabet $2,270.15 / +14.75 (+0.65%) 02/16/21 Tiger Global bought DoorDash and 1Life during Q4, sold out of Alphabet 02/02/21 Alphabet reports Q4 EPS $22.30, consensus $15.90 02/02/21 Notable companies reporting after market close 10/29/20 Alphabet reports Q3 Traffic Acquisition Costs $8.17B vs. $7.49B a year ago GOOGL Alphabet Class A $2,257.06 / +12.325 (+0.55%) 02/16/21 Tiger Global bought DoorDash and 1Life during Q4, sold out of Alphabet 02/02/21 Alphabet reports Q4 EPS $22.30, consensus $15.90 02/02/21 Notable companies reporting after market close 10/29/20 Alphabet CFO sees signs user behavior beginning to return to normalized level GOOG GOOGL GOOG Alphabet $2,270.15 / +14.75 (+0.65%) 13:46 Today Google, ADT expand partnership with pro Nest installation, CNET reports 04/12/21 Chip shortage meeting not seen producing substantive outcomes, Bloomberg says 04/11/21 Google 'Project Bernanke' revealed in Texas antitrust case, WSJ reports 04/09/21 Google tells The Verge the Pixel 5A 5G coming to U.S., Japan later this year GOOGL Alphabet Class A $2,257.06 / +12.325 (+0.55%) 13:46 Today Google, ADT expand partnership with pro Nest installation, CNET reports 04/12/21 Chip shortage meeting not seen producing substantive outcomes, Bloomberg says 04/11/21 Google 'Project Bernanke' revealed in Texas antitrust case, WSJ reports 04/09/21 Google tells The Verge the Pixel 5A 5G coming to U.S., Japan later this year GOOG GOOGL GOOG Alphabet $2,270.15 / +14.75 (+0.65%) 04/07/21 #SocialStocks: AR glasses seen as future of tech 04/07/21 Game On: An exclusive talk with 'Genesis Noir' developer Feral Cat Den 04/06/21 Roku, Starbucks initiations among today's top calls on Wall Street 04/05/21 Fly Intel: Wall Street's top stories for Monday GOOGL Alphabet Class A $2,257.06 / +12.325 (+0.55%) 04/07/21 #SocialStocks: AR glasses seen as future of tech 04/07/21 Game On: An exclusive talk with 'Genesis Noir' developer Feral Cat Den 04/06/21 Roku, Starbucks initiations among today's top calls on Wall Street 04/05/21 Fly Intel: Wall Street's top stories for Monday 04/22/21 Digital Media 04/27/21 Alphabet - GOOG 04/27/21 Alphabet Class A - GOOGL GOOG GOOGL GOOG Alphabet $2,270.15 / +14.75 (+0.65%) 02/02/21 Alphabet options imply 6.6% move in share price post-earnings 11/10/20 Alphabet call volume above normal and directionally bullish 10/30/20 Early notable gainers among liquid option names on October 30th GOOGL Alphabet Class A $2,257.06 / +12.325 (+0.55%) 04/01/21 Unusually active option classes on open April 1st 02/03/21 Early notable gainers among liquid option names on February 3rd 01/20/21 Early notable gainers among liquid option names on January 20th 10/30/20 Early notable gainers among liquid option names on October 30th
Earnings	Kura Sushi reports Q2 adjusted EPS (78c), consensus (78c) » 16:12 04/13/21 04/13 16:12 04/13/21 16:12 KRUS Kura Sushi $31.34 / +0.27 (+0.87%) Reports Q2 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Earnings Events KRUS Kura Sushi $31.34 / +0.27 (+0.87%) 04/06/21 Craig-Hallum Kura Sushi price target raised to $40 from $25 at Craig-Hallum 03/04/21 Stephens Kura Sushi price target raised to $42 from $28 at Stephens 03/03/21 BTIG Kura Sushi price target raised to $40 from $22 at BTIG 01/12/21 Craig-Hallum Kura Sushi upgraded to Buy from Hold at Craig-Hallum KRUS Kura Sushi $31.34 / +0.27 (+0.87%) 01/11/21 Kura Sushi reports Q1 adjusted EPS (71c), consensus (65c) 11/16/20 Kura Sushi reports Q4 EPS (82c), consensus (58c) 17:00 Today Kura Sushi - KRUS
Earnings	Bruker sees Q1 revenue $549M-$554M, consensus $506.86M » 16:12 04/13/21 04/13 16:12 04/13/21 16:12 BRKR Bruker $69.00 / +1.46 (+2.16%) The company states:… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events BRKR Bruker $69.00 / +1.46 (+2.16%) 01/11/21 Seer, Bruker sign commercial agreement for unbiased, deep proteomics 01/04/21 Bruker announces FDA clearance, U.S. launch of MBT Sepsityper Kit US IVD 12/18/20 Bruker launches FluoroType SARS-CoV-2/Flu/RSV PCR panel BRKR Bruker $69.00 / +1.46 (+2.16%) 02/17/21 Stifel Bruker price target raised to $65 from $48 at Stifel 02/17/21 Citi Bruker price target raised to $65 from $57 at Citi 02/05/21 Wells Fargo Bruker downgraded to Equal Weight with $55 target at Wells Fargo 02/05/21 Wells Fargo Bruker downgraded to Equal Weight from Overweight at Wells Fargo BRKR Bruker $69.00 / +1.46 (+2.16%) 02/16/21 Bruker sees FY 21 EPS $1.72-$1.77, consensus $1.71 02/16/21 Bruker reports Q4 EPS 58c, consensus 56c 02/16/21 Bruker reports Q4 EPS 58c, consensus 56c 11/02/20 Bruker says fiscal 2020 guidance remains suspended 21 Oct BRKR Bruker $69.00 / +1.46 (+2.16%) 11/02/20 Fly Intel: After-Hours Movers 05/24/21 Global Healthcare Virtual Conference 2021

Events

Earnings calls, analyst events, roadshows and more

PCYO
Today at 16:30

Pure Cycle - PCYO Conference Calls
AVO
Today at 16:30

Mission Produce, Inc. Firm Sponsored Meetings
LKFN
Today at 16:30

Lakeland Financial Corporation Firm Sponsored Meetings
SEAC
Today at 17:00

SeaChange - SEAC Conference Calls
XELB
Today at 17:00

Xcel Brands - XELB Conference Calls
KRUS
Today at 17:00

Kura Sushi - KRUS Conference Calls
HPQ
Today at 17:00

HP Inc. Firm Sponsored Meetings
BMEA
Tomorrow at 00:00

Biomea Fusion - BMEA Syndicate Roadshows

Virtual Meeting
AKYA
Tomorrow at 00:00

Akoya Biosciences - AKYA Syndicate Roadshows

Virtual Meeting
BOXL
Tomorrow at 00:00

Boxlight - BOXL Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	CHWY X CHWY Chewy Block Trade Managers: Morgan Stanley Priced at: $82.50 6.1M Shares EPRT X EPRT Essential Properties Realty Trust Spot Secondary Managers: Citi, BofA & Barclays Priced at: $23.50 7.15M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial GFL X GFL GFL Environmental Spot Secondary Managers: BMO Capital, RBC Capital & Scotiabank Priced at: $33.95 17.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	ALKT X ALKT Alkami IPO Managers: Goldman Sachs, JPMorgan & Barclays, Citi, William Blair, JMP Securities, KeyBanc, Needham $26.00-28.00 6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	COIN X COIN Coinbase Direct Listing Managers: Direct Listing $ 114.851M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AGL X AGL Agilon Health IPO Managers: JPMorgan, Goldman Sachs & BofA, Deutsche Bank, Wells Fargo, William Blair, Truist, Nomura $20.00-23.00 46.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial APP X APP AppLovin IPO Managers: Morgan Stanley, JPMorgan, KKR, BofA & Citi, Credit Suisse, UBS, Oppenheimer, Stifel, Truist, William Blair, Truist, Luma, Guzman & Company, LionTree Advisors, The Raine Group, Blaylock Van, R. Seelaus $75.00-85.00 25M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EBET X EBET Esports Technologies IPO Managers: Boustead $5.00-6.00 2M Shares KRT X KRT Karat Packaging IPO Managers: Stifel, William Blair & Truist, National Securities, DA Davidson $18.00-20.00 3.95M Shares TSP X TSP TuSimple IPO Managers: Morgan Stanley, Citi & JPMorgan, BofA, Cowen, Credit Suisse, Nomura, RBC Capital, Baird, Needham, Oppenheimer, Piper Sandler, Valuable Capital $35.00-39.00 33.784M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	AKYA X AKYA Akoya Biosciences IPO Managers: JPMorgan, Morgan Stanley, Piper Sandler & Canaccord $18.00-20.00 6.58M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BMEA X BMEA Biomea Fusion IPO Managers: JPMorgan, Jefferies & Piper Sandler $15.00-17.00 7.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RXRX X RXRX Recursion Pharmaceuticals IPO Managers: Goldman Sachs & JPMorgan, BofA, SVB Leerink, Allen & Co., KeyBanc $16.00-18.00 18M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BALY X BALY Bally's Secondary Managers: Deutsche Bank, Goldman Sachs & Barclays $60.80 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

View All Syndicate Announcements »

Pros Holdings management to meet virtually with Needham

TODAY'S FREE FLY STORIES

Get Full Fly Access